Search Results - "MACHENGS, I"

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer by ESPINOSA, E, MORALES, S, JANARIZ, J, DE LA PUENTE, M, CHECA, T, MEL, J. R, GONZALEZ BARON, M, BORREGA, P, CASAS, A, MADRONAL, C, MACHENGS, I, ILLARRAMENDI, J. A, LIZON, J, MORENO, J. A, BELON, J

“…Epirubicin and docetaxel are two of the most active drugs against breast carcinoma. As the achievement of a pathological complete response (pCR) is important…”
Get full text

Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain by Agudo, A, Esteve, M.G, Pallarés, C, Martínez-Ballarín, I, Fabregat, X, Malats, N, Machengs, I, Badia, A, González, C.A

“…A case-control study on women was carried out in Barcelona, Spain, to investigate the relationship of lung cancer with the intake of vegetables, fruits and…”
Get full text

Elevated serum CA 125 tumor marker in chronic. Lymphocytic leukemia with mesothelial involvement by Acin, P., Besses, C., Centelles, M., Machengs, I., Sans‐Sabrafen, J.

Get full text

Docetaxel and carboplatin followed by sequential capecitabine as first line treatment in patients with locally advanced or metastatic breast cancer by Lorenzo, A, Modolell, A, Valero, P, Murillo, L, García-Bueno, JM, Yubero, A, Machengs, I

“…Abstract #2155 Background: Anthracyclines and docetaxel (D) are the most active agents in metastatic breast cancer (BC). New regimens are being assesed to…”
Get full text

Multicenter phase II study of liposomal doxorubicin (M) and docetaxel (T) as neoadjuvant treatment in patients with stage II - III breast cancer by Modolell, A., Mayordomo MD, J. I., Garcia-Bueno, J. M., Machengs, I., Alvarez, I., Centelles, M., Palombo, H., Burillo, M., Yubero, A., Murillo, L., Andrés, R.

“…Abstract only 10662 Background: T and M is a very active chemotherapy regimen for breast cancer. M has been shown to be as effective as doxorubicin at same…”
Get full text

P-145 Metastases resection following FOLFIRI-aflibercept in refractory patients to first-line chemotherapy: safety and efficacy analysis by Muñoz, A., Ruiz Casado, A., Pericay, C., Ibeas Millan, P., Grandez Ladrón de Guevara, R., Díaz Peña, E., Lopez Muñoz Ana, M., González Cebrián, I., Moreno Santos Ma, A., Juez Martel, I., Encinas García, S., Alcaide García, J., Machengs Bruquetas, I., García Adrián, S., Lobo de Mena, M., Higuera, O., Ghanem, I., García Alfonso, P., Rodriguez, N.

Get full text

P-145Metastases resection following FOLFIRI-aflibercept in refractory patients to first-line chemotherapy: safety and efficacy analysis by Munoz, A, Ruiz Casado, A, Pericay, C, Ibeas Millan, P, Grandez Ladron de Guevara, R, Diaz Pena, E, Lopez Munoz Ana, M, Gonzalez Cebrian, I, Moreno Santos Ma, A, Juez Martel, I, Encinas Garcia, S, Alcaide Garcia, J, Bruquetas, Machengs, Garcia Adrian, S, Lobo de Mena, M, Higuera, O, Ghanem, I, Garcia Alfonso, P, Rodriguez, N

Get full text

Coexistence of two hemodynamically significant mechanisms for syncope associated with glossopharyngeal neuralgia by Pujadas, R, Anguera, N, Batalla, N, Abardia, J, Machengs, I, Freixa, E

“…Syncope is a rare presentation of glossopharyngeal neuralgia (GN). A patient with squamous cell cancer of the pharynx had GN and syncope due to asystolic…”
Get more information

Elevated serum CA 125 tumor marker in chronic lymphocytic leukemia with mesothelial involvement by Acín, P, Besses, C, Centelles, M, Machengs, I, Sans-Sabrafen, J

Get full text

Phase II multicenter study of nonpegylated liposomal doxorubicin (A) and docetaxel (T) as neoadjuvant chemotherapy in patients with stage II - III and inflammatory breast cancer (BC) by Andres, R., Garcia-Bueno, J. M., Modolell Catalina Madroñal, A., Mayordomo, J. I., Machengs M Centelles, I., Belon, J., Palombo, H., Burillo, M., Alvarez, I., Lastra Eugenia Ortega Elena Aguirre, R.

“…Abstract only…”
Get full text